Japan Medical Transcription Market

Japan Medical Transcription Market Insights Forecasts to 2035

• The Japan Medical Transcription Market Size Was Estimated at USD 4815.2 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 5.53% from 2025 to 2035
• The Japan Medical Transcription Market Size is Expected to Reach USD 8701.5 Million by 2035

According to a research report published by Decision Advisor & Consulting, the Japan medical transcription market size is anticipated to reach USD 8701.5 million by 2035, growing at a CAGR of 5.53% from 2025 to 2035. The medical transcription market in Japan is driven by rising investments in digital health infrastructure, growing adoption of AI-powered speech recognition, increased EHR integration, and heightened demand for accuracy, security, and efficient clinical documentation processes.

Market Overview

A medical transcription market can be defined as the market where voice-recorded medical reports dictated by physicians and healthcare professionals are transformed into accurate written documents that are structured. The market can include transcription services, voice-to-text software, and AI speech recognition products and platforms integrated with electronic health records. The Japan medical transcription market is growing rapidly as the country hastens the development of its digital health infrastructure under its “Society 5.0” vision, as the government seeks to prioritize interoperability and EHR adoption.  Opportunities are driven by a combination of financing for AI-based speech recognition systems, transcripts of clinical encounters in EHR systems, clinician demand to reduce workload while enhancing the accuracy of clinical documentation, and Ministry of Health support for healthcare DX (digital transformation) technology adoption for clinical documentation. With respect to technology, ASR (automatic speech recognition) and generative AI tools have already proven useful in rapidly creating notes from clinical encounters, while cloud platforms will enable scalable deployment. Recently, several strategic alliances for AI-health have formed, such as FPT Software's partnership with Sumitomo and SBI to establish AI in Japanese health, and the Japanese medical speech recognition software market is expected to grow rapidly.

Report Coverage

This research report categorizes the market for the Japan medical transcription market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan medical transcription market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the Japan medical transcription market.

Driving Factors

The medical transcription market in Japan is driven by the country’s accelerating digital transformation in healthcare, greater adoption of electronic health records, and desire for accurate clinical documentation. Increasing physician workload and administrative burden are creating greater reliance on artificial intelligence-based speech recognition and automated transcription tools. Government policy and support for digitalizing healthcare and interoperability boost adoption even faster. Finally, the focus on patient safety, minimizing errors, and managing clinical data securely contributes to market growth across hospitals and clinics.

Restraining Factors

The medical transcription market in Japan is mostly constrained by strict data privacy regulations, high compliance costs, and limited availability of skilled medical linguists. Resistance to changing workflows, worry about the accuracy of AI, and challenges in integrating transcription with existing legacy hospital systems can also contribute to slowing adoption.

Market Segmentation

The Japan medical transcription market share is classified into service type and end user.

• The discharge summary segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Japan medical transcription market is segmented by service type into history and physical report, discharge summary, operative note or report, consultation report, and others. Among these, the discharge summary segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Discharge summaries are one of the most common transcription demands in hospitals because they are needed medical records for each inpatient episode. To support insurance claims, regulatory compliance, and continuity of care, they must be completed precisely, promptly, and in a consistent manner.

• The hospitals segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Japan medical transcription market is segmented by end user into hospitals, clinics, clinical laboratories, academic medical centers, and others. Among these, the hospitals segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. Hospitals produce the most medical data, such as discharge summaries, operation notes, diagnostic reports, and consultation records, making transcribing critical for workflow efficiency. Japan's aging population raises the demand for documentation via an increase in inpatient admissions and complicated case management.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan medical transcription market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• TXP Medical
• AICRO
• Advanced Media
• OPTiM Corporation
• NEC Corporation
• Wevery
• Welmo
• IBM Japan
• Medimo
• Jetrun Technologies
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments:

• In November 2025, Nanbu Tokushukai Hospital claimed to save approximately200hours a month through the use of Ubie’s AI voice summarization tool used for outpatient consultations / or for preparing discharge summaries.
• In October 2025, Osaka International Cancer Center adopted "nursing voice input generative AI" and "questionnaire generative AI" together with IBM.
• In July 2025, IBM Japan launched a "hospital operations support AI solution" to automatically draft discharge summaries that leveraged both speech recognition and generative AI.

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Decision Advisor has segmented the Japan medical transcription market based on the below-mentioned segments:

Japan Medical Transcription Market, By Service Type

• History and Physical Report
• Discharge Summary
• Operative Note or Report
• Consultation Report
• Others

Japan Medical Transcription Market, By End User

• Hospitals
• Clinics
• Clinical Laboratories
• Academic Medical Centers
• Others

FAQ’s

Q: What is the Japan medical transcription market size?

A: Japan medical transcription market size is expected to grow from USD 4815.2 million in 2024 to USD 8701.5 million by 2035, growing at a CAGR of 5.53% during the forecast period 2025-2035. 

Q: What are the key growth drivers of the market?

A: Market growth is driven by the country’s accelerating digital transformation in healthcare, greater adoption of electronic health records, and desire for accurate clinical documentation. Increasing physician workload and administrative burden are creating greater reliance on artificial intelligence-based speech recognition and automated transcription tools. Government policy and support for digitalizing healthcare and interoperability boost adoption even faster.

Q: What factors restrain the Japan medical transcription market?

A: Constraints include strict data privacy regulations, high compliance costs, and limited availability of skilled medical linguists. Resistance to changing workflows, worry about the accuracy of AI, and challenges in integrating transcription with existing legacy hospital systems can also contribute to slowing adoption.

Q: How is the market segmented by service type?

A: The market is segmented into history and physical report, discharge summary, operative note or report, consultation report, and others.

Q: Who are the key players in the Japan medical transcription market?

A: Key companies include TXP Medical, AICRO, Advanced Media, OPTiM Corporation, NEC Corporation, Wevery, Welmo, IBM Japan, Medimo, and Jetrun Technologies.

Q: Who are the target audiences for this market report?

A: The report targets market players, investors, end-users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).